Permissive Roles of Phosphatidyl Inositol 3-Kinase and Akt in Skeletal Myocyte Maturation

Molecular Biology of the Cell

Volumn 15, Issue 2, 2004, Pages 497-505

  Wilson, Elizabeth M ^a   Tureckova, Jolana ^a   Rotwein, Peter ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; GROWTH FACTOR; MYOCYTE ENHANCER FACTOR 2; MYOD PROTEIN; MYOGENIN; MYOSIN HEAVY CHAIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN B RECEPTOR; TRANSCRIPTION FACTOR; TROPONIN T;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL INTERACTION; CELL MATURATION; CELL REGENERATION; EMBRYO DEVELOPMENT; ENZYME METABOLISM; FIBROBLAST; MOUSE; MULTIGENE FAMILY; MULTINUCLEAR CELL; MUSCLE CELL; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSCRIPTION REGULATION; VIRUS EXPRESSION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMONES; DNA-BINDING PROTEINS; ENZYME INHIBITORS; FIBROBLASTS; MICE; MORPHOLINES; MUSCLE CELLS; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOD PROTEIN; MYOGENIC REGULATORY FACTORS; MYOGENIN; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SOMATOMEDINS; TRANSCRIPTION FACTORS; TROPONIN T;

ADENOVIRIDAE; ANIMALIA;

EID: 0742305350     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E03-05-0351     Document Type: Article

References (49)

1. Apone, S., and Hauschka, S.D. (1995). Muscle gene E-box control elements. Evidence for quantitatively different transcriptional activities and the binding of distinct regulatory factors. J. Biol. Chem. 270, 21420-21427.
2. Barton, E.R., Morris, L., Musaro, A., Rosenthal, N., and Sweeney, H.L. (2002). Muscle-specific expression of insulin-like growth factor 1 counters muscle decline in mdx mice. J. Cell Biol. 157, 137-148.
3. Barton-Davis, E.R., Shoturma, D.I., Musaro, A., Rosenthal, N., and Sweeney, H.L. (1998). Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc. Natl. Acad. Sci. USA 95, 15603-15607.
4. Bennett, A.M., and Tonks, N.K. (1997). Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 278, 1288-1291.
5. Black, B.L., and Olson, E.N. (1998). Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell. Dev. Biol. 14, 167-196.
6. Bodine, S.C., et al. (2001). Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol. 3, 1014-1019.
7. Brazil, D.P., and Hemmings, B.A. (2001). Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 26, 657-664.
8. Buckingham, M. (2001). Skeletal muscle formation in vertebrates. Curr. Opin. Genet. Dev. 11, 440-448.
9. Cho, H., Mu, J., Kim, J.K., Thorvaldsen, J.L., Chu, Q., Crenshaw, E.B.R., Kaestner, K.H., Bartolomei, M.S., Shulman, G.I., and Birnbaum, M.J. (2001a). Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292, 1728-1731.
10. Cho, H., Thorvaldsen, J.L., Chu, Q., Feng, F., and Birnbaum, M.J. (2001b). Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276, 38349-38352.
11. Clemmons, D.R. (1998). Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol. Cell Endocrinol. 140, 19-24.
12. Coleman, M.E., DeMayo, F., Yin, K.C., Lee, H.M., Geske, R., Montgomery, C., and Schwartz, R.J. (1995). Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J. Biol. Chem. 270, 12109-12116.
13. Coolican, S.A., Samuel, D.S., Ewton, D.Z., McWade, F.J., and Florini, J.R. (1997). The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272, 6653-6662.
14. Dinev, D., Jordan, B.W., Neufeld, B., Lee, J.D., Lindemann, D., Rapp, U.R., and Ludwig, S. (2001). Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells. EMBO Rep. 2, 829-834.
15. Dupont, J., and LeRoith, D. (2001). Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction. Horm. Res. (suppl 2) 55, 22-26.
16. Edmondson, D.G., Cheng, T.C., Cserjesi, P., Chakraborty, T., and Olson, E.N. (1992). Analysis of the myogenin promoter reveals an indirect pathway for positive autoregulation mediated by the muscle-specific enhancer factor MEF-2. Mol. Cell Biol. 12, 3665-3677.
17. Engert, J.C., Berglund, E.B., and Rosenthal, N. (1996). Proliferation precedes differentiation in IGF-1-stimulated myogenesis. J. Cell Biol. 135, 431-440.
18. Erbay, E., and Chen, J. (2001). The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism. J. Biol. Chem. 276, 36079-36082.
19. Fujio, Y., Guo, K., Mano, T., Mitsuuchi, Y., Testa, J.R., and Walsh, K. (1999). Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival. Mol. Cell Biol. 19, 5073-5082.
20. James, P.L., Stewart, C.E., and Rotwein, P. (1996). Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism. J. Cell Biol. 133, 683-693.
21. Jiang, B.H., Aoki, M., Zheng, J.Z., Li, J., and Vogt, P.K. (1999). Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B. Proc. Natl. Acad. Sci. USA 96, 2077-2081.
22. Kaliman, P., Vinals, F., Testar, X., Palacin, M., and Zorzano, A. (1996). Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J. Biol. Chem. 271, 19146-19151.
23. Kohn, A.D., Barthel, A., Kovacina, K.S., Boge, A., Wallach, B., Summers, S.A., Birnbaum, M.J., Scott, P.H., Lawrence, J.C.J., and Roth, R.A. (1998). Construction and characterization of a conditionally active version of the serine/threonine kinase Akt. J. Biol. Chem. 273, 11937-11943.
24. Lawlor, M.A., Feng, X., Everding, D.R., Sieger, K., Stewart, C.E., and Rotwein, P. (2000). Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways. Mol. Cell Biol. 20, 3256-3265.
25. Lawlor, M.A., and Rotwein, P. (2000a). Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21. Mol. Cell Biol. 20, 8983-8995.
26. Lawlor, M.A., and Rotwein, P. (2000b). Coordinate control of muscle cell survival by distinct insulin-like growth factor activated signaling pathways. J. Cell Biol. 151, 1131-1140.
27. Montarras, D., Aurade, F., Johnson, T., Ilan, J., Gros, F., and Pinset, C. (1996). Autonomous differentiation in the mouse myogenic cell line, C2, involves a mutual positive control between insulin-like growth factor II and MyoD, operating as early as at the myoblast stage. J. Cell Sci. 109, 551-560.
28. Musaro, A., McCullagh, K., Paul, A., Houghton, L., Dobrowolny, G., Molinaro, M., Barton, E.R., Sweeney, H.L., and Rosenthal, N. (2001). Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat. Genet. 27, 195-200.
29. Musaro, A., McCullagh, K.J., Naya, F.J., Olson, E.N., and Rosenthal, N. (1999). IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400, 581-585.
30. Musaro, A., and Rosenthal, N. (1999). Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I. Mol. Cell Biol. 19, 3115-3124.
31. Nakae, J., Kido, Y., and Accili, D. (2001). Distinct and overlapping functions of insulin and IGF-1 receptors. Endocr. Rev. 22, 818-835.
32. Pallafacchina, G., Calabria, E., Serrano, A.L., Kalhovde, J.M., and Schiaffino, S. (2002). A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc. Natl. Acad. Sci. USA 99, 9213-9218.
33. Paul, A.C., and Rosenthal, N. (2002). Different modes of hypertrophy in skeletal muscle fibers. J. Cell Biol. 156, 751-760.
34. Perry, R.L., Parker, M.H., and Rudnicki, M.A. (2001). Activated MEK1 binds the nuclear MyoD transcriptional complex to repress transactivation. Mol. Cell. 8, 291-301.
35. Polesskaya, A., Naguibneva, I., Fritsch, L., Duquet, A., Ait-Si-Ali, S., Robin, P., Vervisch, A., Pritchard, L.L., Cole, P., and Harel-Bellan, A. (2001). CBP/p300 and muscle differentiation: no HAT, no muscle. EMBO J. 20, 6816-6825.
36. Rommel, C., Bodine, S.C., Clarke, B.A., Rossman, R., Nunez, L., Stitt, T.N., Yancopoulos, G.D., and Glass, D.J. (2001). Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell Biol. 3, 1009-1013.
37. Rommel, C., Clarke, B.A., Zimmermann, S., Nunez, L., Rossman, R., Reid, K., Moelling, K., Yancopoulos, G.D., and Glass, D.J. (1999). Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286, 1738-1741.
38. Sabourin, L.A., and Rudnicki, M.A. (2000). The molecular regulation of myogenesis. Clin. Genet. 57, 16-25.
39. Sartorelli, V., Puri, P.L., Hamamori, Y., Ogryzko, V., Chung, G., Nakatani, Y., Wang, J.Y., and Kedes, L. (1999). Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol. Cell 4, 725-734.
40. Semsarian, C., Wu, M.J., Ju, Y.K., Marciniec, T., Yeoh, T., Allen, D.G., Harvey, R.P., and Graham, R.M. (1999). Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway. Nature 400, 576-581.
41. Shu, L., Zhang, X., and Houghton, P.J. (2002). Myogenic differentiation is dependent on both the kinase function and the N-terminal sequence of mammalian target of rapamycin. J. Biol. Chem. 277, 16726-16732.
42. Stewart, C.E., James, P.L., Fant, M.E., and Rotwein, P. (1996). Overexpression of insulin-like growth factor-II induces accelerated myoblast differentiation. J. Cell Physiol. 169, 23-32.
43. Takahashi, A., Kureishi, Y., Yang, J., Luo, Z., Guo, K., Mukhopadhyay, D., Ivashchenko, Y., Branellec, D., and Walsh, K. (2002). Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth. Mol. Cell Biol. 22, 4803-4814.
44. Tamir, Y., and Bengal, E. (2000). Phosphoinositide 3-kinase induces the transcriptional activity of MEF2 proteins during muscle differentiation. J. Biol. Chem. 275, 34424-34432.
45. Tureckova, J., Wilson, E.M., Cappalonga, J.L., and Rotwein, P. (2001). Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J. Biol. Chem. 276, 39264-39270.
46. Vandromme, M., Rochat, A., Meier, R., Carnac, G., Besser, D., Hemmings, B.A., Fernandez, A., and Lamb, N.J. (2001). Protein kinase B beta/Akt2 plays a specific role in muscle differentiation. J. Biol. Chem. 276, 8173-8179.
47. Weintraub, H., Davis, R., Lockshon, D., and Lassar, A. (1990). MyoD binds cooperatively to two sites in a target enhancer sequence: occupancy of two sites is required for activation. Proc. Natl. Acad. Sci. USA 87, 5623-5627.
48. Wu, Z., Woodring, P.J., Bhakta, K.S., Tamura, K., Wen, F., Feramisco, J.R., Karin, M., Wang, J.Y., and Puri, P.L. (2000). p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol. Cell Biol. 20, 3951-3964.
49. Xu, Q., and Wu, Z. (2000). The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells. J. Biol. Chem. 275, 36750-36757.